Results 51 to 60 of about 86,778 (305)
B‐Type Natriuretic Peptide: A Critical Review [PDF]
Congestive Heart Failure, 2007 Natriuretic peptides have been used as tools for diagnosis and risk stratification in patients with heart failure, myocardial infarction, and unstable coronary syndromes, as well as in the general population. The biology of intra‐assay and intraindividual variations of plasma natriuretic peptide levels is still not clearly understood despite their ...
openaire +2 more sources
Atrial Natriuretic Peptide Protects against Histamine-Induced Endothelial Barrier Dysfunction in Vivo [PDF]
, 2008 Endothelial barrier dysfunction is a hallmark of many severe pathologies, including sepsis or atherosclerosis. The cardiovascular hormone atrial natriuretic peptide (ANP) has increasingly been suggested to counteract endothelial leakage.
Mayer, Bettina A. +9 more
core +1 more source
, 2014 Background: Elevated plasma B-type natriuretic peptide (BNP) levels and their association with heart failure have been reported in subjects with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Oga, T +5 more
core +2 more sources
B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway? [PDF]
, 2012 There is emerging evidence of cross-talk between the myocardium and systemic metabolic pathways. In particular, there is interest in the potential metabolic effects of A-type and B-type natriuretic peptides (ANP and BNP), produced in the myocardial ...
Welsh, P., McMurray, J.J.
core +1 more source
B-type natriuretic peptides: Looking to the future
Annals of Medicine, 2010 Whereas the role of the cardiac natriuretic peptides, ANP and BNP, in some aspects of physiology and pathophysiology is clear, their potential in diagnosis, prognosis, and therapeutics in many clinical disorders remains uncertain. We predict that circulating levels of these peptides will find increasing diagnostic utility in patients presenting with ...
Richard W, Troughton +4 more
openaire +2 more sources
B‐type natriuretic peptide and severity of cognitive disorder [PDF]
European Journal of Clinical Investigation, 2013 AbstractBackgroundNatriuretic peptides have been linked to cognitive disorder in previous studies. The aim of this study was to examine the association between the severity of cognitive disorder and the levels of B‐type natriuretic peptide (BNP) in an older general population.Material and methodsThis study is a part of the larger population‐based ...
Sulkava Raimo +10 more
openaire +2 more sources
Journal of Medical Case Reports, 2012 Introduction Little is known about the responses of natriuretic peptides to developing congestive heart failure in ‘anephric’ end-stage kidney disease.
Ting John YC, Pussell Bruce A
doaj +1 more source
BMJ Open, 2023 Introduction Both B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) are used to identify patients at risk of perioperative vascular events, but prognostic thresholds have been established in a large prospective cohort for NT-pro-BNP ...
P J Devereaux +6 more
doaj +1 more source
B-type natriuretic peptide and cirrhosis progression
Genetics and Molecular Research, 2015 Brain natriuretic peptide (BNP) is used as a marker of cardiac dysfunction to predict heart failure mortality. The significance of the prognostic ability of BNP for liver cirrhosis remains unknown, although the levels of BNP seen in cirrhosis are high. We aimed to determine whether the BNP level is related to the stage of cirrhosis and could serve as a
L Y, Shi +6 more
openaire +2 more sources
Arthritis Care &Research, EarlyView.Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source